Arne Skerra
Chairman bij Gesellschaft Deutscher Chemiker eV
Profiel
Arne Skerra is the founder of Pieris Pharmaceuticals, Inc. (founded in 2001) and Pieris AG (founded in 2001).
He is currently the Chairman of Gesellschaft Deutscher Chemiker eV and a Professor at Technische Universität München.
Dr. Skerra's former position was Chairman-Biological Chemistry at Fachhochschule Weihenstephan.
He received his undergraduate degree from Technische Universität München and his doctorate from Ludwig-Maximilians-Universität München.
Actieve functies van Arne Skerra
| Bedrijven | Functie | Begin |
|---|---|---|
| Technische Universität München | Corporate Officer/Principal | - |
Gesellschaft Deutscher Chemiker eV
 Gesellschaft Deutscher Chemiker eV Miscellaneous Commercial ServicesCommercial Services Gesellschaft Deutscher Chemiker eV operates as a chemical scientific society. The private company is based in Frankfurt am Main, Germany. | Chairman | - |
Eerdere bekende functies van Arne Skerra
| Bedrijven | Functie | Einde |
|---|---|---|
| Fachhochschule Weihenstephan | Corporate Officer/Principal | - |
| PIERIS PHARMACEUTICALS, INC. | Founder | - |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany. | Founder | - |
Opleiding van Arne Skerra
| Technische Universität München | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pieris AG
Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany. | Health Technology |
Gesellschaft Deutscher Chemiker eV
Gesellschaft Deutscher Chemiker eV Miscellaneous Commercial ServicesCommercial Services Gesellschaft Deutscher Chemiker eV operates as a chemical scientific society. The private company is based in Frankfurt am Main, Germany. | Commercial Services |
